Time in Range: How CGM Metrics Can Transform Diabetes Management
Most people with diabetes know their HbA1c number. Itâs the number doctors check every three months to see how well blood sugar is controlled. But hereâs the problem: HbA1c only gives you an average. It doesnât tell you when your blood sugar spikes after lunch, crashes in the middle of the night, or stays high for hours after a walk. Thatâs where Time in Range comes in.
What Time in Range Really Means
Time in Range, or TIR, is simple: itâs the percentage of time your blood glucose stays between 70 and 180 mg/dL (3.9-10.0 mmol/L). Thatâs the sweet spot where your body functions best, without the risks of low or high blood sugar. For most adults with type 1 or type 2 diabetes, the goal is to hit at least 70% TIR - which means spending just over 17 hours a day in that safe zone.
This number isnât theoretical. Itâs measured by continuous glucose monitors (CGMs), devices worn on the arm or belly that check your glucose every 5 minutes. Over a 14-day period, thatâs up to 20,000 data points. Thatâs not just a number - itâs a detailed map of your daily glucose journey.
Compare that to HbA1c. HbA1c is like reading the summary of a book. TIR is reading every chapter. You can have two people with the same HbA1c of 7.0%, but one spends 80% of the day in range, while the other spends 40% of the day above 180 mg/dL and 10% below 70 mg/dL. That second person is at much higher risk - even if their average looks fine.
Why TIR Matters More Than You Think
High blood sugar doesnât just show up as a number on a meter. It damages blood vessels, nerves, and organs over time. But those spikes? Theyâre often invisible without CGM. One patient in Birmingham, whoâd been told his HbA1c was âperfect,â discovered through his CGM that his blood sugar shot above 220 mg/dL every time he ate oatmeal. He thought it was a healthy choice. Turns out, the fiber didnât help - the added sugar in flavored oats did. He switched to plain oats with berries. His TIR jumped from 58% to 82% in six weeks.
Low blood sugar is even more dangerous. Hypoglycemia can cause falls, seizures, or even death. TIR doesnât just tell you how often you go low - it shows you when and why. Maybe your insulin dose is too high before bed. Maybe you skip snacks after exercise. CGM data turns guesswork into action.
The 2025 American Diabetes Association (ADA) Standards of Care now say CGM should be considered for all adults with type 2 diabetes on glucose-lowering meds - not just those on insulin. Thatâs a game-changer. Millions of people who thought they didnât need CGM now have a clear path to better control.
The Numbers Behind the Metric
Hereâs what the data shows:
- For every 10% increase in TIR, HbA1c drops by about 0.5%
- People with TIR above 70% have 40% fewer diabetes-related hospital visits
- Time Below Range (TBR) under 4% (less than 1 hour/day below 70 mg/dL) is linked to lower risk of severe lows
- Time Above Range (TAR) under 25% (less than 6 hours/day above 180 mg/dL) reduces long-term complications
Some researchers are now looking at âTime in Tight Rangeâ - staying between 70 and 140 mg/dL. Thatâs the range most people without diabetes spend most of their day in. Itâs harder to achieve, but for some, especially those with prediabetes or early type 2, itâs a realistic target.
How CGM Turns Data Into Daily Wins
CGM isnât just a tool for tracking. Itâs a teacher. You start seeing patterns:
- Why does your glucose spike 90 minutes after coffee?
- Why does your blood sugar drop after a 20-minute walk but not after a 45-minute one?
- Why does your morning number always rise, even if you didnât eat?
These arenât random. Theyâre clues. One woman in her 60s noticed her glucose jumped every time she took her evening walk after dinner. She thought walking was helping. But the CGM showed she was walking on an empty stomach - her body was releasing stress hormones to make up for low fuel. She started eating a small apple before her walk. Her nighttime lows disappeared. Her TIR improved by 15%.
CGM also helps with medication timing. If you take a pill or shot that peaks at 2 hours, you can now see if itâs working right after meals. No more guessing. No more âI hope it worked.â
Barriers - And How to Overcome Them
Yes, CGM costs money. Yes, some insurance plans still make it hard to get. But things are changing fast. In the U.S., Medicare coverage for CGM in type 2 diabetes jumped from 15% in 2019 to 42% in 2023. In the UK, NHS access is expanding, especially for those with frequent lows or unstable control.
Some people worry about the sensor. Itâs true - wearing a device for two weeks can feel annoying. But newer sensors are thinner, stickier, and more comfortable. Most people forget theyâre wearing it after day two.
And the data? It can feel overwhelming. Thatâs why working with a diabetes educator matters. You donât need to be a scientist. You need to know: What does this line mean? Why did it dip here? What should I try tomorrow? A 30-minute session with a certified educator can turn confusion into clarity.
What Comes Next
The future of diabetes care isnât just about numbers. Itâs about personalization. AI tools are already being tested to predict glucose swings before they happen. Imagine your CGM saying: âYour glucose will drop in 45 minutes. Eat a snack now.â Thatâs not sci-fi - itâs coming.
And as research grows, weâll get better at linking TIR to real outcomes. We already know that higher TIR means fewer hospital visits. Now, weâre starting to see connections to kidney health, nerve damage, and vision - things HbA1c never showed clearly.
For people with type 2 diabetes, especially those not on insulin, this is the first time theyâve had real-time feedback on their glucose. No more waiting three months for a lab result. No more guessing what went wrong.
Time in Range isnât just a metric. Itâs freedom. Freedom to eat without fear. To move without panic. To sleep without dread. Itâs not about perfection. Itâs about staying in the zone - most of the time.
What is a good Time in Range percentage?
For most adults with type 1 or type 2 diabetes, the goal is at least 70% of the day spent between 70 and 180 mg/dL (3.9-10.0 mmol/L). Thatâs about 17 hours out of 24. Some people aim higher - 75% or more - especially if theyâre trying to reduce long-term risks. Pregnant women or those with very stable control may target tighter ranges, like 70-140 mg/dL, but thatâs usually under medical supervision.
How is Time in Range different from HbA1c?
HbA1c gives you an average of your blood sugar over the past 2-3 months. It doesnât show spikes, dips, or patterns. Time in Range, measured by CGM, shows you exactly how much time you spend in, above, or below your target range - hour by hour, meal by meal. Two people can have the same HbA1c but very different daily experiences. TIR reveals those hidden risks.
Can I use Time in Range if I donât take insulin?
Yes. The 2025 ADA guidelines now recommend CGM for all adults with type 2 diabetes on glucose-lowering medications - even if they donât use insulin. Many people on metformin, GLP-1 agonists, or SGLT2 inhibitors benefit from seeing how their food, activity, and medication timing affect their glucose. TIR helps fine-tune those choices.
How long do I need to wear a CGM to get useful TIR data?
For reliable TIR numbers, you need at least 14 days of wear with at least 70% active data collection - meaning the sensor is working and transmitting most of the time. Shorter periods can show trends, but 14 days gives you a full picture across weekdays, weekends, meals, and activity levels. Most experts recommend starting with a 14-day cycle, then repeating every few months to track progress.
What should I do if my Time in Range is low?
Start by looking at your CGM reports. Identify patterns: Do you spike after certain foods? Drop after exercise? Rise in the morning? Try one small change at a time - like eating protein before carbs, adjusting meal timing, or walking 10 minutes after dinner. Keep a simple log: food, activity, sleep, stress. Share it with your diabetes educator. Small, consistent changes add up. Even a 5-10% increase in TIR can lower your risk of complications.
11 Comments
phyllis bourassa
March 8 2026I used to think HbA1c was the whole story until my CGM showed me I was spending 4 hours a day above 200. My doctor said I was 'doing great.' đ Turns out, 'great' just meant I was slowly wrecking my kidneys and nerves. Now I eat plain oatmeal. No more flavored crap. My TIR went from 52% to 81% in 8 weeks. Donât let anyone tell you averages are enough. Youâre not a statistic-youâre a person with a pancreas that deserves better.
amber carrillo
March 10 2026This is exactly why we need to shift from HbA1c-centric care. The data is undeniable. Time in Range gives patients agency. It turns abstract numbers into daily victories. Iâve seen patients regain confidence in their bodies just by seeing patterns. No more guessing. No more shame. Just clarity.
Tim Hnatko
March 11 2026Iâve been using CGM for 18 months. The biggest revelation? Coffee. I thought black coffee was harmless. Nope. Every single morning, my glucose spikes 40 points. Changed to cold brew. Fixed. Also, walking after dinner? Doesnât help unless I eat a protein bite first. Small changes. Huge impact.
Aaron Pace
March 11 2026OMG YES đ I went from 63% TIR to 89% just by eating my carbs LAST. Not first. Not with. LAST. My husband thought I was crazy. Now heâs doing it too. We both lost weight. No more midnight crashes. CGM is basically a personal life coach. đ
Joey Pearson
March 12 2026Stop waiting for perfect. Start with one change. One meal. One walk. One bedtime snack. You donât need to overhaul your life. Just tweak one thing. Then another. Progress isnât linear. But every 1% increase in TIR is a win. Youâve got this.
Roland Silber
March 14 2026The 2025 ADA guidelines are a watershed moment. For years, people on metformin or GLP-1s were told they didnât 'need' CGM. Thatâs like telling someone with asthma they donât need an inhaler because their oxygen levels are 'average.' The science is clear: glucose variability drives complications. Weâre finally catching up.
Patrick Jackson
March 16 2026I used to think diabetes was just a numbers game. Then I saw my graph. The spikes after my wifeâs pasta nights. The crashes after my Sunday hikes. It wasnât just about insulin. It was about love. About family. About the quiet sacrifices we make. CGM didnât just show me glucose-it showed me my life. I cried. Not because I failed. But because I finally saw the truth. đ
Adebayo Muhammad
March 16 2026Letâs be real: the pharmaceutical industry is pushing CGM because itâs profitable. Who benefits? Not you. Not me. The labs, the sensor makers, the clinics. HbA1c is cheap. Reliable. Proven. Why are we being sold this expensive, overhyped gadget as the 'solution'? The real problem is systemic neglect-not lack of data. This is capitalism masquerading as care.
Pranay Roy
March 17 2026You think CGM is helping? Wait till you find out the FDA and CDC are using this data to build predictive health profiles. Your glucose spikes are being sold to insurers. Your 'low TIR' days? Theyâre flagging you for 'high risk' premiums. This isnât health tech-itâs surveillance. They want you dependent on devices so they can control your access to care. Wake up.
Joe Prism
March 18 2026In Nigeria, we donât even have access to basic insulin. But I read this and thought-maybe the real revolution isnât the sensor. Itâs the mindset. That people are finally being asked: What do you feel? When does it hurt? What do you need? This isnât just medicine. Itâs dignity.
Bridget Verwey
March 18 2026I love how people act like CGM is some newfangled gadget. Newsflash: weâve had this tech for over a decade. The real barrier? Doctors who still think 'if it ainât broke, donât fix it.' Meanwhile, patients are out here surviving on guesswork. Iâm not impressed. Iâm just done waiting.